This week’s London appointments: Featuring Hypetex, Nucleus Commercial Finance and Team ITG

This week’s round up of London appointments includes Hypetex, Nucleus Commercial Finance and Team ITG. Read on to find out more.

Michael Dowse, Hypetex

Advanced materials and technology firm Hypetex, the world’s first manufacturer of coloured carbon fibre, has appointed Michael Dowse as a Non-Executive Director and Board Member.

Michael brings a “huge” amount of experience across sport and retail, following leadership roles at some of the biggest sports organisations and companies in the world. He was a global director for Nike before becoming president and general manager Outdoor Americas for Amer Sports, managing brands such as Salomon, Arc’Teryx and Suunto.

As president of Wilson Sporting Goods, Michael led 1,500+ colleagues in delivering the company’s global strategy, corporate operations, and manufacturing across more than 160 countries. He then took up the position of chief executive officer and executive director of the United States Tennis Association, the largest governing body in the sport.

Michael will join a high-level group of advisors at Hypetex, which includes board chairman Neil MacDougall and former Diageo chief financial officer Nick Rose. They will support CEO Marc Cohen and chief technology officer Nigel Dunlea as they continue to expand the company’s presence in sport and other sectors worldwide.

Michael commented: “Hypetex is an incredibly exciting company at the forefront of advanced composites. This sector is growing rapidly, especially in its application to sporting equipment and I’m eager to support this growth through utilising my network and experience.”

Marc Cohen added: “To bring in someone of Michael’s stature and capability is a true testament to the progress that Hypetex has made. I could not imagine a more perfect addition to our board and I’m excited to see how we grow from here.”

Deborah Hardy, Nucleus Commercial Finance

Nucleus Commercial Finance (Nucleus), the solution-led fintech provider, has further strengthened its Group Board with the appointment of Deborah Hardy as an external non-executive director.

With a diverse career background within executive and operational roles, Deborah has over 30 years’ experience and expertise in the overseeing and delivery of strong corporate governance and meeting high DE&I standards.

Alongside her non-exec role on the board, Deborah is currently director of two companies, based in the UK and a further company based in Malta. All of these roles have a focus on operations, delivery and best proactive administration.

As part of the Group Board, Deborah will be contributing to maintaining the effectiveness of internal and external operations and further strengthening relationships between Nucleus’ UK and India based firms, ensuring high quality management between the dual strands of the business, and assisting in the maintenance of Nucleus’ high-quality focus on its people.

Deborah commented: “The growth opportunities for Nucleus are huge and I’m looking forward to using my experience to assist with the overall management and strategic direction of the company. With the business operating on two continents, staff engagement and productivity will be central to our success.

“With my prior experience overseeing the delivery of operations and administrative communication, I am confident that I can play a central role in unlocking the potential within the business and seizing the opportunities posed by the year ahead.”

Gerhard Arnhofer, Team ITG

Industry veterans Gerhard Arnhofer and Jase George have joined forces at Team ITG to spearhead the expansion of a dedicated Life Sciences division, leading technology transformation programs & marketing campaigns for companies across the biopharma, medical devices & consumer care sectors including Bayer, Johnson & Johnson and Haleon.

Gerhard (pictured left) joins as the head of customer strategy for Team ITG’s Life Science division, with two decades of experience in the biopharmaceutical industry, including Merck & Co. Inc., Bayer AG and most recently BioNTech SE, where he oversaw commercial activities within the Immunology, Oncology and Product & Services business units.

Arnhofer joins Jase George (pictured right), managing partner for Team ITG’s Life Science division, who has 30 years of experience across companies including Pfizer Inc., Merck & Co., Inc., Novartis AG & Bayer AG.

Jase took over Team ITG’s Lifescience portfolio at Team ITG in 2021 and will lead the division’s growth strategy through the deployment of its proprietary Storyteq marketing collaboration and creative automation platform, in addition to its suite of professional services.

Gerhard commented: “Automation is the key to unlocking unprecedented potential within the Life Science industry. Commercial and Medical organisations will need to hyper-personalise their conversations with their customers, to explain complex treatment pathways, modes of action and patient challenges.

“You know my life’s mission is to create impact in healthcare; this is why I joined Team ITG as Storyteq will make a difference worldwide.”

Would you like to see your businesses new hires or promotions featured in the Bdaily appointments news?

Send your submissions to: editor@bdaily.co.uk with ‘APPOINTMENT:’ In the subject.

Submissions should:

• include the name and job title of the appointee and the business name
• be no longer than six paragraphs/250 words
• include a landscape photograph of the appointee
• include a quote
• detail the respective businesses social media handles.

Appointments are published entirely at the discretion of the Bdaily team. Submission does not guarantee publication.

By Matthew Neville – Senior Correspondent, Bdaily

• Add me on LinkedIn and Twitter to keep up to date
• And follow Bdaily on Facebook, Twitter and LinkedIn
• Submit press releases to editor@bdaily.co.uk for consideration.

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →